MARKET

RDHL

RDHL

Redhill Biopharm
NASDAQ
0.5025
+0.0147
+3.01%
After Hours: 0.5099 +0.0074 +1.47% 17:54 09/30 EDT
OPEN
0.4948
PREV CLOSE
0.4878
HIGH
0.5100
LOW
0.4810
VOLUME
1.51M
TURNOVER
0
52 WEEK HIGH
6.50
52 WEEK LOW
0.4726
MARKET CAP
26.76M
P/E (TTM)
-0.2646
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Ontrak (NASDAQ:OTRKP) shares increased by 28.8% to $2.1 during Monday's pre-market session.
Benzinga · 5d ago
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Investor Place · 5d ago
Why Golden Ocean Group Is Trading Higher By 7%; Here Are 28 Stocks Moving Premarket
Gainers
Benzinga · 5d ago
Top Premarket Gainers
Top Premarket Gainers
MT Newswires · 5d ago
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday.
Benzinga · 5d ago
RedHill (RDHL) Up on Orphan Drug Tag for NTM Disease Drug
RedHill's (RDHL) RHB-204 gets Orphan Drug designation from the European Commission for the treatment of nontuberculous mycobacteria (NTM) disease
Zacks · 08/18 15:04
RedHill Shares Gain As European Commission Grants Orphan Drug Status To NTM Infections Candidate
The European Commission has granted Orphan Drug Designation to RedHill Biopharma’s  (NASDAQ: RDHL) lead asset RHB-204 for the treatment of nontuberculous mycobacteria (NTM) disease.
Benzinga · 08/17 14:55
RedHill Biopharma Shares Pop On European Orphan Tag For Lung Disease Candidate
The European Commission granted orphan drug status to RedHill Biopharma Ltd's (NASDAQ: RDHL) RHB-2041 for nontuberculous mycobacteria (NTM) disease. NTM is a lung disease caused by ubiquitous environmental bacteria in soil and natural and engineered water ...
Benzinga · 08/17 14:12
More
About RDHL
Redhill Biopharma Ltd is an Israel-based specialty biopharmaceutical company, principally focused on gastrointestinal (GI) and infectious diseases. The Company is focused on the commercialization in the United States (U.S.) of the GI-related products, Movantik (naloxegol),Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). A part form Company's pipeline consists of six therapeutic candidates RHB-204 dedicated to Nontuberculous mycobacterial (NTM) treatment, RHB-104 dedicated to Crohn's disease, RHB-102 antiemetic drug ondansetron, in development for multiple gastrointestinal indications, RHB-106 an oral capsule formulation for bowel preparation, Opaganib an inhibitor, administered orally, with anticancer, anti-inflammatory and anti-viral activities and RHB-107 inhibitor of serine proteases targeting multiple indications, including COVID-19, cancer, inflammatory lung diseases and gastrointestinal diseases.

Webull offers kinds of RedHill Biopharma Ltd (ADR) stock information, including NASDAQ:RDHL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RDHL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RDHL stock methods without spending real money on the virtual paper trading platform.